Washam, J. B., Hohnloser, S., Wojdyla, D., Vinereanu, D., Alexander, J., Lopes, R., … Granger, C. (2017). USE OF INTERACTING DRUGS DID NOT MODIFY TREATMENT EFFECTS OF APIXABAN VERSUS WARFARIN FOR ATRIAL FIBRILLATION: RESULTS FROM THE ARISTOTLE TRIAL. In Journal of the American College of Cardiology (Vol. 69, pp. 442–442). Elsevier BV. https://doi.org/10.1016/s0735-1097(17)33831-7

Washam, Jeffrey B., Stefan Hohnloser, Daniel Wojdyla, Dragos Vinereanu, John Alexander, Renato Lopes, Bernard Gersh, et al. “USE OF INTERACTING DRUGS DID NOT MODIFY TREATMENT EFFECTS OF APIXABAN VERSUS WARFARIN FOR ATRIAL FIBRILLATION: RESULTS FROM THE ARISTOTLE TRIAL.” In Journal of the American College of Cardiology, 69:442–442. Elsevier BV, 2017. https://doi.org/10.1016/s0735-1097(17)33831-7.

Washam JB, Hohnloser S, Wojdyla D, Vinereanu D, Alexander J, Lopes R, et al. USE OF INTERACTING DRUGS DID NOT MODIFY TREATMENT EFFECTS OF APIXABAN VERSUS WARFARIN FOR ATRIAL FIBRILLATION: RESULTS FROM THE ARISTOTLE TRIAL. In: Journal of the American College of Cardiology. Elsevier BV; 2017. p. 442–442.

Washam, Jeffrey B., et al. “USE OF INTERACTING DRUGS DID NOT MODIFY TREATMENT EFFECTS OF APIXABAN VERSUS WARFARIN FOR ATRIAL FIBRILLATION: RESULTS FROM THE ARISTOTLE TRIAL.” Journal of the American College of Cardiology, vol. 69, no. 11, Elsevier BV, 2017, pp. 442–442. Crossref, doi:10.1016/s0735-1097(17)33831-7.

Washam JB, Hohnloser S, Wojdyla D, Vinereanu D, Alexander J, Lopes R, Gersh B, Hanna M, Horowitz J, Hylek EM, Husted S, Xavier D, Verheugt FWA, Wallentin L, Granger C. USE OF INTERACTING DRUGS DID NOT MODIFY TREATMENT EFFECTS OF APIXABAN VERSUS WARFARIN FOR ATRIAL FIBRILLATION: RESULTS FROM THE ARISTOTLE TRIAL. Journal of the American College of Cardiology. Elsevier BV; 2017. p. 442–442.